Tennessee Theatre Killer Vincente Montano, 29 Diagnosed with Paranoid Schizophrenia

This recent attempted murder of his family is one of a long line of Theater, Malls and Campus killing areas in 2015. A person who is diagnosed paranoid schizophrenic will be given psychotropic drugs. The kind of drugs that are prescribed to treat schizophrenia is a long long list. Some of these are Seroquel, Abilify, Zyprexa, Risperdal, Latuda, Invega and many many more. Too many more.

Many have seen these drugs commercials where people are smiling, laughing, enjoying friends in the outdoors. As if these drugs take a person who is paranoid schizophrenic into happiness. Where is the truth in advertising?

Well Vincente Montano was homeless, and wearing dingy cloths according to witnesses. He was not the happy TV commercial or magazine image that is portrayed by these drug pushers. He was reported missing by his family just two days before. Additionally, he had been committed four times to mental health “professionals”

So do you really think psychiatry works? Do you really think psychiatry is the answer? If this was an act of terror by outside forces then a full analysis and criminal investigations would be taken to address it. But if it is a mental health issue then the media and the government will not confront the drug makers or psychiatry "doctors". No, there is too much money in psych drugs to do that.

If you thinking of putting your child or loved one on psych drugs, then think of all the theaters, malls and campuses where these killings and attempted murders take place.
There are other real solutions to psych drugs. Read more find out more. There are natural remedies, non-drug remedies. Dianetics and Scientology are real methods that address issues of depression and problems in people’s lives. These are practical non drug methods to improve a person’s situation in life.

Senator Targets Abusive High Prescribing Antipsychotic Medicaid Doctors

Senator Grassley contacted all States to request statistics of top prescribing doctors in 2006. Senator Grassley is an Iowa Republican and he recently sent letters to some thirty states asking what those states have done to investigate over prescribing doctors of antipsychotics. Well some of the states are not doing so well in tackling this problem. Florida has allowed several physicians to continue to subscribe to Medicaid patients. Even though there is at least an appearance of prescription fraud and elder abuse.

According to ProPublica a number of the top-prescribing Medicaid doctors around the country are listed twelve pharmaceutical companies in payments to physicians for speaking and consulting Medicaid. These were jointly funded by the states and federal government, providing health care coverage to about 60 million low income enrollees. Also according to ProPublica Grassley’s letter to Ohio notes that the top prescriber of the anti-psychotic Abilify wrote 13,825 prescriptions in 2009 which is about 54 prescriptions per weekday. Ohio paid $6.7 million for that those prescriptions, state officials reported to Grassley. There are reports of almost 20,000 prescriptions of Seoquel at a Medicaid cost of almost $6 million. This noted by Grassley is nine prescriptions an hour.
Senator Grassley was quoted “If state and federal taxpayers are being cheated because of inappropriate prescriptions,” Grassley said, “the state and federal governments have to get to the bottom of it and stop it.”
We applaud the Senator for attacking this issue head on. Not just for the potential financial gain to these doctors and losses to the US tax payers, but also for the massive drugging of older Americans. These doctors are taking advantage of the most vulnerable of citizens all for money. They are tarnishing their own profession. At least one Senator is making the charge. Now we need the public to contact their local and state representative to push them investigate this grave and disgusting practice. There is a link on our website and here http://www.statelocalgov.net/ All citizens will be older in time. Do you want this to happen to you or to ones you love?

Why would a 7 year old Foster Child Commit Suicide by Hanging? The Number One Culprit Today is BigPharma and Psychiatry

Senator Rhonda Storms is forwarding a Florida Senate Bill 2718 through the legislator that can prevent similar unfortunate deaths. From CBSnews Edicio Martinez-The apparent suicide of 7-year old Gabriel Myers, who was taking several psychiatric medications, has led to the introduction of a bill in the Florida legislature. It would assure that powerful mental health drugs dispensed to Florida foster care children would be more closely monitored. It is now moving through the Florida legislature.
The proposal is largely based on the findings of a task force formed after Gabriel locked himself in a bathroom and hung himself with a shower cord last April. Gabriel at the time of his death was on Seroquel "Quetapine Fumerate" made by Astra Zenaca which is too commonly prescribed by psychiatrists to treat bipolar disorder. Seroquel and other psychiatric drugs have been linked by federal regulators for their potentially dangerous side effects, including suicide, but the side effects and risks have not been communicated to foster parents. There has been an enormous amount of foster kid’s overprescribed psychotropic drugs particularly in Florida, but also across the US. The measure would require an independent review before psychotropic drugs can be administered to children under ten. Senator Storms is pushing for more “talk therapy”, because of the over prescription of antidepressants by psychiatry.
Senator Storms has also asked the Florida Board of Medicine and the Agency for
Health Care Administration to investigate the Broward County psychiatrists who prescribed the drugs to little Gabriel. The Miami Herald reports that one doctor has been red flagged by the Board of Medicine, but no disciplinary action thus far.

It is all about the money. Psychiatrist’s see a patient in less than fifteen minutes and prescribed a drug with fatal side effects. They simply have no care for the patient. This unnecessary death shows the heartless and disaffected indifference for young children caught in the system. Without a parent to defend them they are left to disinterested doctors to just prescribe a drug that they know doesn’t work. When will it end? It will only end when mother and fathers wake up and smell what is brewing.

Florida-Court Case Regarding Psychiatrist Overmedicating a Disabled Boy

CAROL MARBIN MILLER of the Miami-Herald reported recently that the mother of a disabled boy who died in 2007 has filed a wrongful death suit in Miami-Dade County against Dr. Steven Kaplin for overmedicating Denis Maltez, 12. The mother is outraged after her son committed suicide after taking a lethal cocktail of four mental health drugs: Seroquel and Zyprexa, both anti-psychotic medications; Depakote, an anti-seizure drug sometimes , which is used to stabilize moods, and Clonazepam, a tranquilizer.

We at Stoprx.org recognize this as another case of psychiatrists only solution to control a teenager is drugs. They add one drug after another to hopefully control or restrain the teenager. The continued overmedication of teens in the US is astounding. The psychiatric community should be embarrassed that more and more of these wrongful death, suicides, and mass murders are all taking place while they are assisting these teens to improve. It's a case of the insane helping the depressed.

We don’t see the improvement coming anytime soon. We see teens being perscribed more and more drugs, and needing more and more assistance with no solution or end in sight. When do you think BigPharma, and psychiatry will get the message that they have no idea what they are doing? Unfortunately it will be never. These Psychiatrists are the same doctors who used electric shock treatment, straight jackets, and lobotomies. Today they use pills, which have side effects causing suicide, mass murder or at best a need for another pill. Now they have President Obama and the US Congress working more on their behalf. The Mothers Act has been introduced three times already and has failed twice. The Mothers Act will enforce all pregnant mothers to see a psychiatrist during her pregnancy, which will be administered by her hospital. This will essentially place all infant Americans on antidepressants. This is George Orwell’s 1984 worst nightmare coming true. All Americans are under threat to be on BigPharma’s drugs from cradle to grave. These drugs don’t do anything but put someone into apathy, or on the front page as a campus mass murderer. The next generation of Americans has become a “new normal” a medicated generation.

We applaud Martha Quesada, the mother of 12-year-old Denis Maltez, filing of the wrongful death suit. We hope more and more of these lawsuits come to light, and more and more of the West become aware of just what these drugs are and are not.

To Move More Prescription Drugs, Sales Reps Sling Swag

This is an article from the St. Petersburg Times which says it all. Doctors continually on the BigPharma take, and unethical sales representatives risking other peoples lives for a dollar. The end result is push the drugs and dosage even if the patient doesn’t need it. Do you still trust your doctor?

By Kris Hundley
St. Petersburg Times Sunday, April 5, 2009

A busy Panama City Fla. Physician had no problem leaving patients to stew in the waiting room while he listened to a pitch about Seroquel from a persistent saleswoman.
"Dr had 3 pat (patients) waiting and did sit down w (with) me," the rep wrote after a series of snubs at the front desk. "You never know what you will get w/dr b."
Every day, legions of drug reps troop into doctors' offices, then scoot back to their cars and enter notes about their encounters onto laptops or handheld devices. They include reminders about everything from medical questions to the doctor's new Nissan 350Z or his kid's Eagle Scout badge.
The notes are uploaded to a secure database at company headquarters and used by the drug rep, her partners and managers as the company refines its sales spiel.
Thanks to thousands of lawsuits pending against Seroquel, AstraZeneca's best-selling antipsychotic, hundreds of pages of call notes concerning several Florida doctors recently were made public. Though specific to Seroquel, the salespeople's notes reflect industry-wide practices. They give insights into what happens behind closed doors while patients cool their heels.
It's not a pretty picture, with sales reps laying on the swag and doctors complaining about late honoraria and angling to get on the AstraZeneca's "advisory board."
Company spokesman Tony Jewell said the drug maker's philosophy is that "any interaction with health care providers should be about providing information that helps them decide on the right medicines, for the right patients, at the right time."
But notes from pharma's emissaries reflect two different goals: Get the doctor to prescribe the drug. Then push him to boost the dosage.
A sales rep in Jacksonville was ecstatic when a nurse practitioner prescribed Seroquel at twice the dosage used by the psychiatrist in the same practice.
"Gave him goodies," the rep wrote. "Biggest user of Seroquel in the office!"
•
AstraZeneca's sales reps have worked wonders. Though approved only for schizophrenia and bipolar disorder, relatively rare mental illnesses, Seroquel has been one of the world's best sellers. Last year sales reached $4.5 billion.
But Seroquel's widespread use for everything from insomnia to anxiety has also triggered lawsuits alleging the drug caused weight gain, diabetes and other health problems. AstraZeneca, a U.K.-based company, denies the charges, noting that the FDA has repeatedly upheld the safety of Seroquel.
It also has denied that its salespeople illegally promoted unapproved, or off-label, uses of the drugs to doctors. Reps "are trained to ensure that every product promotion discussion with (a) health care provider conforms to the FDA-approved prescribing information," Jewell said.
Company lawyers vigorously opposed unsealing sales reps' notes, saying they contained confidential, proprietary information. But at a recent hearing in Orlando's federal court, AstraZeneca agreed to release call notes from before January 2004, when Seroquel received FDA approval for bipolar mania.
Heavily redacted, the notes comprise what the company's commercial brand leader, Alfred Paulson, described as sales reps' "continuous conversation" with a half-dozen Florida health care providers who prescribed Seroquel to plaintiffs in pending lawsuits.
Depicting sales pitches, on which millions of dollars of revenue hinge, as simple "conversations" is an apt description for what, in the end, comes down to the chemistry between two people. Shahram Ahari, a drug rep for competitor Eli Lilly & Co. in 1999 and 2000, now lectures physicians on how to avoid being manipulated by well-trained marketing reps.
"As much as doctors want to think the relationship with a sales person is about the transfer of knowledge, it's the affinity between two people that's the big money-maker for the drug company," said Ahari, who is part of Pharmedout.org, a physician-education group in Washington, D.C. "That's why drug companies hire former cheerleaders and athletes as drug reps instead of scientists. It's a question of how gregarious and engaging you can be."
While AstraZeneca declined to comment on its employees' compensation, industry data shows drug reps earn an average of nearly $100,000 a year, including bonuses based on sales.
They learn sales techniques more often associated with door-to-door soliciting than medical offices. Doc too busy to see you? Send in several sales people, daily if necessary, until you get a sit-down. Show up on rainy days when patients cancel. And even highly paid physicians find it hard to resist a free lunch.
In 1999, Seroquel reps tried to waylay Dr. Maria Carmen Wilson, the Tampa neurologist, four times before hitting gold.
"We were able to speak to her at lunch that we brought for the office," a rep wrote.
Wilson moved from free food to free trips to medical meetings in Spain and Scotland. By early 2002, a drug rep noted that Wilson was using a "ton of Seroquel" for patients with migraines.
Wilson, who says she was surprised to learn that drug reps recorded their interactions with her, denies that she was ever a big Seroquel prescriber. Despite her initial hopes, she says the drug did not turn out to be effective against chronic headaches.
"I still use it in low doses for people with intractable insomnia," said Wilson, an associate professor at the University of South Florida. "But I make sure patients are acutely aware of the potential for weight gain, especially if they have a predisposition to diabetes."
Wilson says the industry-funded jaunts to Europe did not unduly influence her.
"I went because I want to be up-to-date and learn," she said of the seminars, which she did not report, as required, to USF officials. "But frankly, I'd prefer they were in Orlando."
•
The call notes show that massaging doctors' egos consumed an inordinate amount of a drug rep's time.
Saleswomen in Miami quickly honed in on psychiatrist Dr. Heriberto Cabada's need for extra schmoozing. "Would not pay attention, all about him," wrote one frustrated sales rep in 2001. So the line worker pulled in a "customer solutions" specialist who offered to redo the doc's patient history forms with a personalized logo.
She agreed to Cabada's demands for multiple revisions, "one side only and ... marbled type paper." More attention was funneled his way through a "preceptorship," in which a sales rep shadows the doctor for the day and pays for the honor.
In a few months, Cabada went from prescribing what he called "chicken dosages" of Seroquel to higher doses. Soon after his conversion, however, Cabada closed his practice and moved to Spain, where he now lives. He did not respond to an e-mail seeking comment.
Drug reps are taught to use free samples as a strategic weapon: Parcel them out sparingly, even if there are box loads in the trunk.
"It makes the doctor even more grateful," said former Lilly rep Ahari. "And when he gives a freebie to the patient, the doctor feels like a hero."
Dribbling samples out in small caches, and requiring the doctor's signature each time, also gives the rep another chance at valuable face time.
"Samples are key to access," wrote a sales rep who was routinely brushed off by Dr. John Roy Billingsley in Panama City.
AstraZeneca said it has voluntarily banned many of its "reminder" giveaways to docs — free pens, pads and hand wash emblazoned with drug names. But the company declined to say how such changes have affected its spending on physicians.
Ahari said he doubts drug companies have pared back their marketing budgets. "The money going to influence physicians is exactly the same,'' he said.
"There's absolutely no enforcement of these voluntary guidelines. All the incentives are still in place to wine and dine doctors at Hooters if he needs to."
The reason: it works.
Case in point: Dr. Mohamed O. Saleh, a Jacksonville psychiatrist who was involved in early clinical studies of Seroquel. In 1998, he was telling AstraZeneca reps that their product wasn't effective and two years later he was still dodging salesmen.
By 2003, however, the rep was crowing that Saleh "really loves seroquel for elderly... said that he would — dose of 800 (mg) and even higher if necessary!"
Saleh and his nurse practitioner, Richard Daniel Malcolm, were wooed with everything from holiday treats ("Left pumpkin candy baskets ... put seroquel labels on them") to a video of Saleh for his use during a visit to Africa in 2002.
AstraZeneca also furnished Saleh with freebies for the trip. The payoff: the doctor told the drug rep he would put a picture on his Web site showing "African healthcare workers holding the Seroquel bags filled with (a text book) and pens/etc. Appreciated our support."
Saleh, who said in July that he is still receiving $10,000 to $15,000 a year as a speaker for Seroquel, seemed aware of the persuasive power of drug company payola. In October 2003, he told AstraZeneca reps that he was concerned about his nurse practitioner, who had taken a fishing trip with the Seroquel rep and was pushing for his own speaking gigs.
"Concerned about payments to Dan (Malcolm) and can be inducement for scripts b/c paying so much," wrote one of the two reps assigned to Saleh's office.
Malcolm joined Saleh's office in June 2001, four months after he was disciplined by the Florida Board of Medicine for pleading guilty to charges of domestic battery, driving with a suspended license and fraud in obtaining a medicinal drug.
Neither Saleh nor Malcolm returned calls or e-mails seeking comment.
•
When doctors complained that patients were ballooning up on Seroquel, sales reps often handed them a study by Chicago psychiatrist Dr. Michael J. Reinstein. Its startling message: "Use of S (Seroquel) to reduce weight and reduce risk," according to a salesman who visited Panama City's Billingsley.
Back at headquarters, however, company executives had serious questions about the validity of Reinstein's findings. "Our clinical colleagues have significant and numerous issues in the past with the quality of research that this group has produced," a note from Seroquel's brand manager said in 2001.
While sales reps were not allowed to explicitly promote Seroquel for anything other than schizophrenia prior to 2004, the notes reflect a not-so-subtle, broad-based push.
In early 2000, Billingsley's sales rep wrote, "S best in new Schizo's, kids, adolescents, bi-pols, blacks and asians."
Dr. Guido Nodal, Jr., a psychiatrist in Hialeah, at first was cautious about Seroquel, fearing potential links to cataracts. In late 2001, he told a male sales rep he would keep the drug in mind only for "smoking sciz pts."
Two months later, however, a female rep wrote that Nodal "LOVES SER. FOR ELDERLY." By year's end he had 15 nursing home patients on the drug. (Later the FDA made all antipsychotics warn that use in elderly with dementia could cause death.)
"Claims that he is switching patients from Risperdal to Seroquel at the nursing homes," a sales rep wrote in 2003. "Writing as much as he can to all patients."
Notes show that in the interim, Nodal received a textbook, mug, penlights ("Using lots"), payment for a preceptorship and dinner at Ruth's Chris Steak House. He denies the giveaways influenced his prescribing.
"If drug companies stopped marketing, I think prescribing (patterns) would be more or less the same as they are now,'' said Nodal, who said he tried to become a Seroquel speaker but was not accepted. "It didn't affect me at all."
Nodal closed his private practice last year and now works for the state's Department of Corrections in Florida City. The agency does not allow drug reps to lobby its physicians.